In addition to injectable steroids such as, for example, drostanolone enanthate or propionate, there is also an oral steroid which is comparable with drostanolone in the effects and which can achieve extremely good results particularly in the diet and for the competition preparation. Oral steroids are often considered to be very damaging because of their 17-alpha alkylation, which can adversely affect the liver and kidneys. In addition, the strong aromatase of oral steroids is also feared, which surprisingly disappears in Superdrol (methyldrostanolone). All you should know about this topic is here:
Methyldrostanolone was first developed by the firm Syntex in 1959, but it was never granted marketing authorization as a drug. In 2005, Superdrol (methyldrostanolone) was sold for the first time in the USA as a pro anabolic food supplement under the name Superdrol. It is known, however, that Superdrol (methyldrostanolone) is an anabolic and androgenic steroid.
Structurally, Superdrol (methyldrostanolone) is very similar to the known anabolic steroid drostanolone. This was also confirmed by the Food and Drug Administration in the USA in 2006, whereby the production and distribution of Superdrol (methyldrostanolone) was forbidden.
As the name suggests, Superdrol (methyldrostanolone) is a drostanolone derivative attached to a c17 methylene group. This makes the anabolic steroid orally available, in contrast to conventional injectable drostanolone, which makes it very effective even at low doses, which is inter alia associated with the extremely high bioavailability. Superdrol (methyldrostanolone) is 4 times as anabolic as methyltestosterone and has only 20% of the androgenic side effects of methyltestosterone, resulting in significantly fewer side effects compared to this anabolic steroid. Another extreme advantage of Superdrol (methyldrostanolone) is that it does not convert to estrogen when compared to most other anabolic steroids.
In principle, the effect of Superdrol (methyldrostanolone) can be compared with that of classical drostanolone. Superdrol (methyldrostanolone) cannot be converted into estrogen as already mentioned, which in practice means that the user does not have to worry about estrogen-induced side effects such as water retention or gynecomastia. But the interesting aspects of Superdrol (methyldrostanolone) with regard to the estrogen start only at this point actually. If you look at the original medicinal use of drostanolone, you will find that drostanolone has not been used to build body tissue but as a drug for the treatment of certain types of breast cancer in women. This field of use of Superdrol (methyldrostanolone) is based on the ability of the active substance drostanolone to reduce the aromatization (conversion into estrogen) of corporeal testosterone - and, of course, also of exogenously supplied aromatic anabolic androgenic steroids - by an inhibition of the aromatase enzyme. It is also assumed that Superdrol (methyldrostanolone) additionally interacts with estrogen by blocking the estrogen receptors and thus reducing the effect of already existing estrogen. This means for the user that the estrogen-induced side effects of other anabolic androgenic steroids can be reduced with the aid of Superdrol (methyldrostanolone) and that the use of an additional aromatase inhibitor such as Arimidex or an estrogen receptor blocker such as tamoxifen (Nolvadex) may be omitted.
In addition, the use of Superdrol (methyldrostanolone) promotes lipolysis (release of fat from the fat cells) and increases the number of androgen receptors in adipose tissue, which promotes fat reduction. Furthermore, androgenic components of Superdrol (methyldrostanolone) increase aggression, which can have a positive effect on the training intensity especially in the context of a calorie-reduced diet.
For beginners, a dosage of 10mg daily is enough to get good results. Advanced athletes take two times 10mg daily. However, this dosage should not be exceeded.
An application should not exceed 6 weeks of treatment due to the many-sided and, above all, organ-damaging side effects.
In addition to all steroid-like side effects such as the acceleration of hereditary hair loss, acne and libidoproblems, 17-alpha-alkylation in Superdrol (methyldrostanolone) leads to a high burden on the liver and kidneys. For this reason, the application should only be performed under medical supervision in order to prevent fatal side effects.